SARTOR.STED.B. EO-,20SARTOR.STED.B. EO-,20SARTOR.STED.B. EO-,20

SARTOR.STED.B. EO-,20

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪16.34 B‬EUR
1.75EUR
‪309.70 M‬EUR
‪2.78 B‬EUR
‪25.69 M‬
Beta (1Y)
1.21
Employees (FY)
‪10.66 K‬
Change (1Y)
‪−1.27 K‬ −10.66%
Revenue / Employee (1Y)
‪287.32 K‬EUR
Net income / Employee (1Y)
‪32.06 K‬EUR

About SARTORIUS STED BIO


CEO
René Fáber
Headquarters
Aubagne
Founded
1978
ISIN
FR0013154002
FIGI
BBG000R5C7J9
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 56S1 is 168.00 EUR — it has increased by 1.96% in the past 24 hours. Watch SARTOR.STED.B. EO-,20 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SARTOR.STED.B. EO-,20 stocks are traded under the ticker 56S1.
56S1 stock has fallen by −8.21% compared to the previous week, the month change is a −20.00% fall, over the last year SARTOR.STED.B. EO-,20 has showed a −16.29% decrease.
We've gathered analysts' opinions on SARTOR.STED.B. EO-,20 future price: according to them, 56S1 price has a max estimate of 310.00 EUR and a min estimate of 134.00 EUR. Watch 56S1 chart and read a more detailed SARTOR.STED.B. EO-,20 stock forecast: see what analysts think of SARTOR.STED.B. EO-,20 and suggest that you do with its stocks.
56S1 reached its all-time high on Sep 13, 2021 with the price of 553.80 EUR, and its all-time low was 51.25 EUR and was reached on Oct 18, 2017. View more price dynamics on 56S1 chart.
See other stocks reaching their highest and lowest prices.
56S1 stock is 0.48% volatile and has beta coefficient of 1.21. Track SARTOR.STED.B. EO-,20 stock price on the chart and check out the list of the most volatile stocks — is SARTOR.STED.B. EO-,20 there?
Today SARTOR.STED.B. EO-,20 has the market capitalization of ‪16.33 B‬, it has decreased by −8.44% over the last week.
Yes, you can track SARTOR.STED.B. EO-,20 financials in yearly and quarterly reports right on TradingView.
SARTOR.STED.B. EO-,20 is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
56S1 earnings for the last quarter are 0.76 EUR per share, whereas the estimation was 0.80 EUR resulting in a −4.68% surprise. The estimated earnings for the next quarter are 0.97 EUR per share. See more details about SARTOR.STED.B. EO-,20 earnings.
SARTOR.STED.B. EO-,20 revenue for the last quarter amounts to ‪655.40 M‬ EUR, despite the estimated figure of ‪685.76 M‬ EUR. In the next quarter, revenue is expected to reach ‪710.61 M‬ EUR.
56S1 net income for the last quarter is ‪25.50 M‬ EUR, while the quarter before that showed ‪47.60 M‬ EUR of net income which accounts for −46.43% change. Track more SARTOR.STED.B. EO-,20 financial stats to get the full picture.
Yes, 56S1 dividends are paid annually. The last dividend per share was 0.69 EUR. As of today, Dividend Yield (TTM)% is 0.41%. Tracking SARTOR.STED.B. EO-,20 dividends might help you take more informed decisions.
SARTOR.STED.B. EO-,20 dividend yield was 0.29% in 2023, and payout ratio reached 20.53%. The year before the numbers were 0.48% and 15.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪10.66 K‬ employees. See our rating of the largest employees — is SARTOR.STED.B. EO-,20 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SARTOR.STED.B. EO-,20 EBITDA is ‪637.60 M‬ EUR, and current EBITDA margin is 26.02%. See more stats in SARTOR.STED.B. EO-,20 financial statements.
Like other stocks, 56S1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SARTOR.STED.B. EO-,20 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SARTOR.STED.B. EO-,20 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SARTOR.STED.B. EO-,20 stock shows the strong sell signal. See more of SARTOR.STED.B. EO-,20 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.